Nuclease Probe Technologies - About the company
Nuclease Probe Technologies is a seed company based in Lowell (United States), founded in 2018 by James McNamara. It operates as a Developer of pathogen detection tests. Nuclease Probe Technologies has raised $500K in funding from Breakout Labs. The company has 93 active competitors, including 14 funded and 9 that have exited. Its top competitors include companies like Embark Veterinary, Hendrix Genetics and AnimalBiome.
Company Details
Developer of pathogen detection tests. The company has developed a phenotypic antibiotic susceptibility test (AST) which identifies the type of infection from blood samples and suggests the appropriate antibiotic for it. The company is also developing bloodstream pathogen detection tests, urine pathogen detection tests, and nuclease tests for circulating tumor cells.
- Website
- nptrapidtesting.com
- Social
- Email ID
- *****@nptrapidtesting.com
Key Metrics
Founded Year
2018
Location
Lowell, United States
Stage
Seed
Total Funding
$500K in 1 round
Latest Funding Round
Investors
Ranked
47th among 93 active competitors
Employee Count
3 as on Jul 01, 2024
Similar Companies
Sign up to download Nuclease Probe Technologies' company profile
Nuclease Probe Technologies's funding and investors
Nuclease Probe Technologies has raised a total funding of $500K over 1 round. Its latest funding round was a Seed round on Mar 05, 2019 for $*****. 1 investor participated in its latest round. Nuclease Probe Technologies has 1 institutional investor.
Here is the list of recent funding rounds of Nuclease Probe Technologies:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 05, 2019 | 1582545 | Seed | 6113298 | 8091663 | 7478377 | 3349719 |
Access funding benchmarks and valuations. Sign up today!View details of Nuclease Probe Technologies's funding rounds and investors
Nuclease Probe Technologies' founders and board of directors
Founder? Claim ProfileThe founders of Nuclease Probe Technologies is James McNamara.
Here are the details of Nuclease Probe Technologies' key team members:
- James McNamara: Founder & CEO of Nuclease Probe Technologies.
View details of Nuclease Probe Technologies's Founder profiles and Board Members
Nuclease Probe Technologies' employee count trend
Nuclease Probe Technologies has 3 employees as of Jul 24. Here is Nuclease Probe Technologies's employee count trend over the years:
Uncover Nuclease Probe Technologies' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Nuclease Probe Technologies's Competitors and alternates
Top competitors of Nuclease Probe Technologies include Embark Veterinary, Hendrix Genetics and AnimalBiome. Here is the list of Top 10 competitors of Nuclease Probe Technologies, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Embark Veterinary 2015, Austin (United States), Series B | Proivder of DNA test kits for dogs that enable dog owners to provide better pet care | $94.3M | 69/100 | |
2nd | Hendrix Genetics 2005, Boxmeer (Netherlands), Acquired | Provider of breeding programs for multiple animal species and related technologies | - | 58/100 | |
3rd | AnimalBiome 2016, San Francisco (United States), Series B | Provider of animal microbiome based diagnostics services for pet care | $25.9M | 54/100 | |
4th | Basepaws 2016, Mountain View (United States), Acquired | Provider of genetic testing for cats | $250K | 51/100 | |
5th | Bactana Corporation 2016, Farmington (United States), Seed | Developer of proprietary microbiome technology | $1.76M | 43/100 | |
6th | Proteon Pharmaceuticals 2005, Lodz (Poland), Series B | Developer of bacteriophage-based products for livestock farming and aquaculture health | $28.8M | 43/100 | |
7th | _1536061718349.png?devicePixelRatio=2&height=30&width=30){kind=logo} BioPet Laboratories 2008, Knoxville (United States), Unfunded | Provider of DNA proof test for parentage of canines | - | - | 41/100 |
8th |  PetDx 2019, San Diego (United States), Deadpooled | Developer of liquid biopsy technology for detection of cancer in dogs | $72M | 41/100 | |
9th |  MiDOG 2018, Irvine (United States), Unfunded | Provider of DNA Sequencing for identification of pathogens and antibiotic resistances in dogs | - | - | 38/100 |
10th | Provider of genetic testing services for pet animals | - | - | 37/100 | |
47th | Nuclease Probe Technologies 2018, Lowell (United States), Seed | Developer of pathogen detection tests | $500K | 24/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Nuclease Probe Technologies's competitors? Click here to see the top ones
Nuclease Probe Technologies's Investments and acquisitions
Nuclease Probe Technologies has made no investments or acquisitions yet.
Reports related to Nuclease Probe Technologies
Here is the latest report on Nuclease Probe Technologies's sector:
Are you a Founder ?
FAQs about Nuclease Probe Technologies
Explore our recently published companies
- Geospatial Collaborative - Tucson based, 2017 founded, Unfunded company
- samra - Unfunded company
- Facilities Online - New York based, 1986 founded, Unfunded company
- Caledoniasiu - United States based, Unfunded company
- 66Togoship - Unfunded company
- Esports Ohio - Tiffin based, 2018 founded, Unfunded company
